What it means

A UK medicine’s licence specifies the uses and circumstances assessed by the regulator. Using it outside those terms—for example for another condition, age group, dose or route—is called off-label use. That is different from using a product that has no applicable UK licence.

In context

Off-label prescribing can be appropriate when a prescriber judges it justified by evidence and the person’s needs. It carries responsibilities for explaining treatment, monitoring and follow-up. Off-label does not mean proven ineffective, automatically recommended or regulator-approved for that use. NICE recommendations and local funding decisions are separate questions from the product licence.

Sources and References

  1. Off-label or unlicensed use of medicines: prescribers’ responsibilities

    Scope: United Kingdom.

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top